These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 34676904

  • 1. circCORO1C promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing the expression of PD-L1 through NF-κB pathway.
    Wu F, Sun G, Zheng W, Tang W, Cheng Y, Wu L, Li X, Tao J, Ma S, Cao H.
    J Clin Lab Anal; 2021 Dec; 35(12):e24003. PubMed ID: 34676904
    [Abstract] [Full Text] [Related]

  • 2. Circular RNA hsa_circ_0005239 contributes to hepatocellular carcinoma cell migration, invasion, and angiogenesis by targeting the miR-34a-5p/PD-L1 axis.
    He T, Huang J, Liang H, Zhong B, Xu G, Zhu X.
    Cell Biol Int; 2023 Sep; 47(9):1519-1534. PubMed ID: 37208963
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization.
    Wang Y, Gao R, Li J, Tang S, Li S, Tong Q, Li S.
    Int J Nanomedicine; 2021 Sep; 16():2803-2818. PubMed ID: 33880025
    [Abstract] [Full Text] [Related]

  • 4. Hsa_circ_0079875 functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression.
    Liu Y, Luo X, Chen W, Dong Z, Cheng T, Chen L, Ju L, Cai W, Bian Z.
    Cell Cycle; 2024 Mar; 23(5):519-536. PubMed ID: 38684479
    [Abstract] [Full Text] [Related]

  • 5. Oncogenic hsa_circ_0091581 promotes the malignancy of HCC cell through blocking miR-526b from degrading c-MYC mRNA.
    Wei X, Zheng W, Tian P, He Y, Liu H, Peng M, Li X, Liu X.
    Cell Cycle; 2020 Apr; 19(7):817-824. PubMed ID: 32116112
    [Abstract] [Full Text] [Related]

  • 6. Exosomal hsa_circ_0004658 derived from RBPJ overexpressed-macrophages inhibits hepatocellular carcinoma progression via miR-499b-5p/JAM3.
    Zhang L, Zhang J, Li P, Li T, Zhou Z, Wu H.
    Cell Death Dis; 2022 Jan 10; 13(1):32. PubMed ID: 35013102
    [Abstract] [Full Text] [Related]

  • 7. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
    Li X, Shen M.
    Eur Rev Med Pharmacol Sci; 2019 Feb 10; 23(2):555-566. PubMed ID: 30720163
    [Abstract] [Full Text] [Related]

  • 8. ESRP1-mediated biogenesis of circPTPN12 inhibits hepatocellular carcinoma progression by PDLIM2/ NF-κB pathway.
    Ji Y, Ni C, Shen Y, Xu Z, Tang L, Yu F, Zhu L, Lu H, Zhang C, Yang S, Wang X.
    Mol Cancer; 2024 Jul 11; 23(1):143. PubMed ID: 38992675
    [Abstract] [Full Text] [Related]

  • 9. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
    Gong J, Du C, Sun N, Xiao X, Wu H.
    J Gene Med; 2021 Jun 11; 23(6):e3332. PubMed ID: 33783904
    [Abstract] [Full Text] [Related]

  • 10. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM, Cao Y, Zhao PS, Wu LY, Lu YM, Wang YL, Zhao JF, Liu XG.
    Int J Biol Sci; 2022 Jun 11; 18(2):637-651. PubMed ID: 35002514
    [Abstract] [Full Text] [Related]

  • 11. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.
    Liu G, Guo W, Rao M, Qin J, Hu F, Li K.
    Cell Transplant; 2020 Jun 11; 29():963689720963948. PubMed ID: 33028110
    [Abstract] [Full Text] [Related]

  • 12. Piplartine attenuates the proliferation of hepatocellular carcinoma cells via regulating hsa_circ_100338 expression.
    Cheng X, Tian P, Zheng W, Yan X.
    Cancer Med; 2020 Jun 11; 9(12):4265-4273. PubMed ID: 32281302
    [Abstract] [Full Text] [Related]

  • 13. Circular RNA hsa_circ_0051040 Promotes Hepatocellular Carcinoma Progression by Sponging miR-569 and Regulating ITGAV Expression.
    Ju L, Yao M, Lu R, Cao Y, Wang H, Yuan L, Xiao F, Shao J, Cai W, Chen L, Bian Z.
    Cells; 2022 Nov 11; 11(22):. PubMed ID: 36429000
    [Abstract] [Full Text] [Related]

  • 14. Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression.
    Zhou L, Wang Q, Hou J, Wu X, Wang L, Chen X.
    BMC Cancer; 2023 Jul 03; 23(1):611. PubMed ID: 37400785
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of hsa_circ_0000711 expression level on proliferation and apoptosis of hepatoma cells.
    Chen KH, Pan JF, Chen ZX, Pan D, Gao T, Huang M, Huang JN.
    Eur Rev Med Pharmacol Sci; 2020 Apr 03; 24(8):4161-4171. PubMed ID: 32373952
    [Abstract] [Full Text] [Related]

  • 17. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J, Liu H, Jin M, Li W, Xu H, Wei F.
    Aging (Albany NY); 2020 Jun 18; 12(12):11623-11635. PubMed ID: 32554866
    [Abstract] [Full Text] [Related]

  • 18. A hsa_circ_001726 axis regulated by E2F6 contributes to metastasis of hepatocellular carcinoma.
    Ai J, Zhang W, Deng W, Yan L, Zhang L, Huang Z, Wu Z, Ai J, Jiang H.
    BMC Cancer; 2024 Jan 02; 24(1):14. PubMed ID: 38166853
    [Abstract] [Full Text] [Related]

  • 19. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN, Qiao GL, Yu J, Yang CM, Chen Y, Deng ZF, Song LH, Ma LJ, Yan HL.
    J Exp Clin Cancer Res; 2020 Jun 17; 39(1):114. PubMed ID: 32552766
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.